RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD)

Olivier K. N.; Eagle G.; McGinnis J. P. II; Micioni L.; Daley C. L.; Winthrop K. L.; Ruoss S.; Addrizzo-Harris D. J.; Flume P.; Dorgan D.; Salathe M. A.; Brown-Elliot B. A.; Wallace R.; Griffith D. E.

首页> 外文期刊>Pediatric Pulmonology >RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD)

【24h】

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD)

机译：脂蛋白阿米卡星用于治疗非结核性非结核性细菌性肺病（NTM-LD）的吸入性（LAI）随机，双盲，局部对照研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2014年第38期|共1页
作者
Olivier K. N.; Eagle G.; McGinnis J. P. II; Micioni L.; Daley C. L.; Winthrop K. L.; Ruoss S.; Addrizzo-Harris D. J.; Flume P.; Dorgan D.; Salathe M. A.; Brown-Elliot B. A.; Wallace R.; Griffith D. E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD) [J] . Olivier K. N., Eagle G., McGinnis J. P. II, Pediatric Pulmonology . 2014,第Suppla38期

机译：脂蛋白阿米卡星用于治疗非结核性非结核性细菌性肺病（NTM-LD）的吸入性（LAI）随机，双盲，局部对照研究
2. In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex [J] . Shulha Jennifer Mayo Clinic Proceedings . 2020,第1期

机译：在答复 - Amikacin脂质体吸入悬浮液作为难治性厌备的难治性厌备的治疗选择，由厌备分枝杆菌繁殖
3. Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex [J] . Swenson Colin, Del Parigi Angelo Mayo Clinic Proceedings . 2020,第1期

机译：Amikacin脂质体吸入悬浮液作为难治性无抗性的分枝杆菌肺病的治疗选择，由分枝杆菌复合物引起
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease [O] . Kenneth N. Olivier, David E. Griffith, Gina Eagle, -1

机译：脂质体阿米卡星吸入性治疗非结核性分枝杆菌肺疾病的随机试验
7. Stability and Consistency of Treatment Effect With Liposomal Amikacin for Inhalation (LAI) as Add-on Therapy in Patients With Pulmonary Nontuberculous Mycobacterial (PNTM) Infection [O] . Quanwu Zhang, George Georges, John McGinnis, 2016

机译：用脂质体Amikacin进行治疗效果的稳定性和一致性，作为肺结核（PNTM）感染患者的加入治疗（LAI）作为肺癌患者的添加疗法

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD)

著录项

相似文献

相关主题

期刊订阅